2022 - Pharmacist Digest

GPhC November pass rate drops again to 2022 levels

The Pharmacist

DECEMBER 17, 2024

This brings the pass rates back down almost to November 2022 levels of 56%, following a 10% rise to 66% in November 2023. And it comes as summer pass rates have seen a steady decline […] The post GPhC November pass rate drops again to 2022 levels appeared first on The Pharmacist.

Diabetes

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

The Pharmacist

JANUARY 2, 2025

This represents 4% of the 1,444 pharmacies eligible to claim funding under the scheme set up to 'capture the pharmacies that are most important for patient access, those […] The post More than 50 Access Scheme pharmacies have closed since 2022, NPA claims appeared first on The Pharmacist.

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT

MARCH 4, 2025

Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.

U.S. government spent more on health care in 2022 than six countries with universal health care combined

STAT

DECEMBER 19, 2023

trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 American taxpayers footed the bill for at least $1.8 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services.

The 2022 PharmaVoice 100

PharmaVoice

SEPTEMBER 6, 2022

From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

STAT

NOVEMBER 29, 2023

The 2022 rise was mainly due to the waning pandemic, Centers for Disease Control and Prevention researchers said Wednesday. NEW YORK — U.S. life expectancy rose last year — by more than a year — but still isn’t close to what it was before the Covid-19 pandemic. But even with the large increase, U.S.

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT

JANUARY 14, 2025

billion in revenue by dispensing medicines to treat cancer, HIV, heart disease and other serious illnesses at prices that exceeded their estimated acquisition costs between 2017 and 2022. Specifically, the companies were able to generate more than $7.3 Continue to STAT+ to read the full story…

Drug Pricing

Drug Pricing Drug Development

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT

MARCH 3, 2025

In 2022, a U.S. The long-running federal lawsuit was settled on the eve of trial on Sunday. It would have been the second time the case, Sidibe v. Sutter Health, was tried before a jury. appeals court determined that a judge’s error caused the jury to miss out on crucial details and overturned Sutter’s win.

Hospitals

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT

DECEMBER 11, 2023

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $1.2 billion last year, according to a new report.

Drug Pricing

The end-of-life doula: Making smooth the paths of people on the journey to death

STAT

MARCH 12, 2025

The struggles she has seen in her community led her to seek more training to help people face death, and in 2022 she added another credential to her spiritual one: end-of-life doula. A major aspect of her job is guiding her congregants through their most vulnerable moments from birth throughout life. since 2012.

STAT+: Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors

STAT

JANUARY 24, 2025

The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to prescribe Nurtec ODT, the centerpiece of the $11.6 Department of Justice. billion acquisition.

STAT+: AstraZeneca says China has detained a senior executive

STAT

NOVEMBER 6, 2024

Before joining Beigene in January 2022, Yin had worked for AstraZeneca for more than 15 years and was general manager of its oncology business in China. The individuals, who were detained last summer, are all Chinese citizens who marketed drugs in the oncology division. Continue to STAT+ to read the full story…

High sensitivity cardiac troponins for ED chest pain evaluation (2022 ACC pathway)

ALiEM - Pharm Pearls

FEBRUARY 9, 2024

The 2022 American College of Cardiology (ACC) pathway provides timely guidance [1]. Applying the 2022 ACC guideline Before delving into the specifics of the hs-cTn pathways, start with the ECG. The ACC 2022 pathway has a section dedicated to ECGs in ischemia [1], and FOAMcast has a great visual summary.

Hospitals

Hospitals Diabetes

STAT+: Moderna CEO made $398 million in 2022, but still pledges to give most to charity

STAT

MARCH 17, 2023

Bancel made $398 million in 2022 based on the actual realized gains of stock that was exercised and sold, according to STAT’s calculations from Moderna’s annual compensation disclosure filed this week.

Vaccines

Study reveals how often medical device makers report safety incidents late to FDA

STAT

MARCH 13, 2025

million manufacturer reports between 2019 and 2022, about 600,000, or nearly 14% came in late. In a new study in the BMJ , researchers analyzed the Food and Drug Administration database where manufactures report adverse events and found that a huge number of reports come in late. Over 600,000 came in with missing or invalid dates.

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT

OCTOBER 29, 2024

The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and access to prescription drugs for millions of people with Medicare. The law laid out aggressive timelines for implementing the Medicare Drug Price Negotiation Program.

Drug Pricing

Opinion: Gene therapy trials should emphasize transparency, not secrecy

STAT

DECEMBER 20, 2024

Two other deaths due to acute reactions and organ toxicity in early commercial use of the same viral vector occurred in 2022. He had received a similar viral vector via a different route of administration, carrying a different genetic cargo.

STAT+: Biotech accelerator Curie.Bio raises $340 million for a new seed fund

STAT

JANUARY 29, 2025

Since 2022, Curie.Bio has received some 4,000 applications. Borisy and Weinberg’s firm was created to upend the biotech financing model , offering both capital and expert assistance to founders seeking on option outside of traditional VC funding. It has invested in 26 startups, giving it a less than 1% acceptance rate.

Drug Development

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

MARCH 10, 2025

In 2022, the Mayo Clinic signed a five-year partnership with the dairy checkoff, a program overseen by the U.S. But a partnership between the dairy industry and the Mayo Clinic, one of the top-ranked health systems in the U.S., is drawing criticism for its potential to undermine the Minnesota powerhouse’s credibility.

Mayo Clinic

Mayo Clinic Communication Hospitals

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT

APRIL 15, 2024

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome, supporting the company’s decision to acquire its development partner two years ago.

Communication

STAT+: Health tech investments are picking up steam. Here are 5 VC leaders behind the biggest recent deals

STAT

OCTOBER 30, 2024

Health tech investments are showing signs of resilience following the perilous lows of 2022 and 2023: Just this past month, two startups that analysts believe might be getting ready for IPOs raised more than $100 million in late-stage funding rounds.

Diabetes

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT

SEPTEMBER 30, 2024

billion combined last year, compared with $4 billion in 2022. million in 2022. But the biggest names in health care still made $3.5 The average chief executive brought home $11 million, while the median was $4.1 Those figures compared to an average of $13 million and median of $4.3

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Hospitals

STAT+: After a big donor sought care from a Dana-Farber cancer doctor, things went awry

STAT

MARCH 17, 2025

So after Cohen died in 2022 of complications from Covid-19 at a hospital near his suburban Washington, D.C., It was no problem for the physician to pause a Sunday morning walk with his wife to weigh in on test results, respond to a 5:50 a.m.

Hospitals

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

STAT

NOVEMBER 7, 2023

The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequately tested and treated. Read the rest…

Opinion: To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen

STAT

JUNE 24, 2024

Suicide rates in the United States increased approximately 36% between 2000 and 2022, according to updated data from the National Center for Health Statistics. Suicide was responsible for just under 50,000 deaths in 2022 (the last year with complete statistics) — an all-time high.

Routine vaccinations drop among U.S. kindergartners for the third year in a row

STAT

JANUARY 12, 2023

kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S.

Vaccines

What will it take to end health care worker burnout?

STAT

OCTOBER 26, 2023

Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…

Hospitals

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

STAT

MAY 15, 2024

drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022. Last year saw 107,543 U.S. Read the rest…

Overdose deaths hit another record but show signs of leveling off

STAT

MARCH 20, 2024

recorded 107,941 drug overdose deaths in 2022, according to a new federal report — a total that marks an all-time record but also shows signs that the country’s overdose rate may finally be leveling off after years of steady increase.

Antiviral used for mpox no better than placebo, NIH says

STAT

AUGUST 15, 2024

The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe. Read the rest…

Lyme disease cases rise, but largely due to a change in data collection

STAT

FEBRUARY 15, 2024

A new report released Thursday by the Centers for Disease Control and Prevention appears to show that Lyme disease cases in the United States rose by 69% in 2022 over previous years. The change, an attempt to lift a crushing reporting burden off the shoulders of states where Lyme disease infections are common, went into effect in 2022.

As Covid deaths drop, heart disease and cancer remain leading causes of death

STAT

AUGUST 8, 2024

lower than 2022. Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. Overall, deaths in 2023 were 6.1% Read the rest…

Opinion: Hospital care costs are out of control. Price caps can help

STAT

APRIL 4, 2024

trillion in 2022 , finding ways to cut costs has become increasingly urgent. Private health insurance premiums paid by working age adults are rising rapidly. Many Americans skip necessary medical care, while those who do get treated can end up bankrupt. health care spending reaching $4.5 Read the rest…

Hospitals

STAT+: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

STAT

OCTOBER 10, 2024

in 2022, breaking a decade-long trend of nearly continuous annual increases in the share of graduates headed for the private sector. in 2022 to 22.1%. in 2022 and 66% in 2021. in 2022 and 66% in 2021. That’s a sizable dip from 66.5% That trend suggests that among Ph.D.

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

STAT

JULY 6, 2023

Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. In 2022, they made up a majority of the company and management. The percentage of managers who are people of color remains the same in 2022 as it was in 2015, at 20%. population.

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

STAT

JANUARY 30, 2024

syphilis epidemic isn’t abating, with the rate of infectious cases rising 9% in 2022, according to a new federal government report on sexually transmitted diseases in adults. NEW YORK — The U.S. But there’s some unexpected good news: The rate of new gonorrhea cases fell for the first time in a decade.

Scientists spot an orangutan using a plant to treat his own wound in the wild

STAT

MAY 2, 2024

Which is likely how Rakus, an adult male orangutan frequently seen in Gunung Leuser National Park in South Aceh, Indonesia, acquired a face wound in June 2022. Things can get tense.

Report: Measles cases and deaths increase worldwide, as childhood vaccinations rates decline

STAT

NOVEMBER 16, 2023

Estimated measles cases rose 18% to 9 million in 2022 when compared to the previous year, and deaths rose by 43% to 136,200, according to the report , jointly authored by the World Health Organization and the Centers for Disease Control and Prevention.

Vaccines

‘Concern is real’ about long Covid’s impact on Americans and disability claims, report says

STAT

JUNE 6, 2024

A new report commissioned by the SSA in 2022 captures what we know so far about long Covid, and hints at how the nation’s disability benefits system might need to shift in the wake of the pandemic. That could change as the burden of long Covid becomes clearer. Read the rest…

Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests

STAT

MAY 22, 2024

Nearly 30 million adults in the United States have alcohol use disorder, according to the 2022 National Survey on Drug Use and Health. The data, presented this week as an abstract at Digestive Disease Week in D.C., Read the rest…

Labelling

Federal officials and physician groups express outrage over revelations of recent coercive sterilizations

STAT

JUNE 6, 2024

Federal officials, medical organizations, and reproductive health advocacy groups have expressed outrage in response to STAT’s recent investigation revealing that women with sickle cell disease have felt pressured into sterilizations as recently as 2017 and 2022.

Opinion: The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments

STAT

JANUARY 31, 2024

In 2022, it supported a petition before the World Trade Organization to gut intellectual property protections for Covid-19 vaccines. The Biden administration may soon double down on one of its gravest mistakes.

Vaccines

After Amylyx drug failure, what’s next for ALS?

PharmaVoice

MARCH 15, 2024

The company’s combo treatment Relyvrio was approved in 2022, but after failing a phase 3 trial, may be pulled from the market.

STAT+: How biotech deal-making really works behind the scenes, according to founders

STAT

OCTOBER 20, 2023

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6

GPhC November pass rate drops again to 2022 levels

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

Trending Sources

Opinion: Herding cats: It’s past time to include pets in disease surveillance

U.S. government spent more on health care in 2022 than six countries with universal health care combined

The 2022 PharmaVoice 100

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

The end-of-life doula: Making smooth the paths of people on the journey to death

STAT+: Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors

STAT+: AstraZeneca says China has detained a senior executive

High sensitivity cardiac troponins for ED chest pain evaluation (2022 ACC pathway)

STAT+: Moderna CEO made $398 million in 2022, but still pledges to give most to charity

Study reveals how often medical device makers report safety incidents late to FDA

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

Opinion: Gene therapy trials should emphasize transparency, not secrecy

STAT+: Biotech accelerator Curie.Bio raises $340 million for a new seed fund

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT+: Health tech investments are picking up steam. Here are 5 VC leaders behind the biggest recent deals

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT+: After a big donor sought care from a Dana-Farber cancer doctor, things went awry

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

Opinion: To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen

Routine vaccinations drop among U.S. kindergartners for the third year in a row

What will it take to end health care worker burnout?

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

Overdose deaths hit another record but show signs of leveling off

Antiviral used for mpox no better than placebo, NIH says

Lyme disease cases rise, but largely due to a change in data collection

As Covid deaths drop, heart disease and cancer remain leading causes of death

Opinion: Hospital care costs are out of control. Price caps can help

STAT+: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

Scientists spot an orangutan using a plant to treat his own wound in the wild

Report: Measles cases and deaths increase worldwide, as childhood vaccinations rates decline

‘Concern is real’ about long Covid’s impact on Americans and disability claims, report says

Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests

Federal officials and physician groups express outrage over revelations of recent coercive sterilizations

Opinion: The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments

After Amylyx drug failure, what’s next for ALS?

STAT+: How biotech deal-making really works behind the scenes, according to founders

Stay Connected